Pfizer Gets CDSCO Panel Nod To Conduct Phase III Trial of RSV Vaccine in India, Told to Clarify Subject Criteria Dr. Divya Colin13 July 2025 1:00 PM ISTNew Delhi: Pfizer has received approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation...
Pfizer's Abrocitinib Phase III Data Accepted by CDSCO Expert Committee Parthika Patel6 July 2025 10:00 AM ISTNew Delhi: The Subject Expert Committee (SEC) under the Dermatology and Allergy division of the Central Drugs Standard Control Organisation (CDSCO)...
Pfizer Told To Conduct Phase IV Trial of Abrocitinib in Indian Adolescents with Atopic Dermatitis Parthika Patel4 July 2025 3:00 PM ISTNew Delhi: In a recent regulatory development, the Subject Expert Committee (SEC) under the Dermatology and Allergy division of the Central Drugs...
Pfizer: Reshma Parida to become new Senior Director - People Experience Ruchika Sharma3 July 2025 3:57 PM ISTMumbai: Pfizer has announced the appointment of Reshma Parida as the new Senior Director - People Experience, effective August 1, 2025. ...
Pfizer Gets CDSCO Panel Nod to Conduct Phase IIIb Trial of Rimegepant for Menstrual Migraine Parthika Patel28 Jun 2025 7:23 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drugs Standard Control Organisation (CDSCO) has granted Pfizer Limited...
CORONA Remedies appoints four Independent Directors to its board Ruchika Sharma24 Jun 2025 3:15 PM ISTAhmedabad: CORONA Remedies Limited, backed by Sepia Investments Limited, an affiliate of ChrysCapital, has appointed Ameetkumar Hiranyakumar...
Pfizer loses patent lawsuit to SK Bioscience over Pneumococcal Vaccine Ruchika Sharma24 May 2025 10:30 AM ISTSeongnam: SK bioscience, a global vaccine and biotech company, has announced that the Supreme Court of Korea has ruled in its favor in a patent...
Pfizer strikes cancer drug deal with China's 3SBio Ruchika Sharma20 May 2025 11:30 AM IST3SBio plans to initiate the first Phase 3 study in China in 2025.
Pfizer Gets CDSCO Panel Nod To study Anti-cancer Drug Disitamab vedotin Dr. Divya Colin17 May 2025 6:00 PM ISTNew Delhi: Pfizer has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) to...
Pfizer discontinues development of danuglipron for chronic weight management Ruchika Sharma14 April 2025 5:41 PM ISTNew York: Pfizer Inc. has announced the company has discontinued the development of danuglipron (PF-06882961), an oral glucagon-like...
GSK, Pfizer resolve patent lawsuit over RSV vaccines Ruchika Sharma8 April 2025 5:10 PM ISTPfizer and GlaxoSmithKline have agreed to end a lawsuit over alleged patent infringement involving their competing respiratory syncytial virus (RSV)...
Pfizer Gets CDSCO Panel Nod To study Marstacimab Dr. Divya Colin4 April 2025 6:00 PM ISTNew Delhi: The pharmaceutical major Pfizer has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
